More Features
Applying pharmacometabolomic data for personalized medicine
LifeSciencesIntelligence As healthcare evolves and science advances, the industry has increasingly focused on personalized medicine as an alternative to blanket, one-size-fits-all treatments. This approach is an attempt to address ongoing concerns around treatment...
Addressing muscle loss associated with GLP-1 medication use
PharmaNewsIntelligence Glucagon-like peptide-1 (GLP-1) receptor agonists — also known as GLP-1 drugs — have gained a significant amount of attention in recent years because of their utility in managing type 2 diabetes (T2D) and, even more so, in...
Tailoring medication selection with pharmacogenomic testing
PharmaNewsIntelligence In modern healthcare, pharmacogenomic assessments are helping healthcare providers determine medication selection, ensuring tailored treatment plans for everyone’s unique genetic makeup. Pharmacogenomic Testing Drug–gene...
Protecting patient data sharing & ownership with ethical data use
PatientEngagementHIT In pursuit of consumer-centered healthcare, the medical industry has seen the growing prominence of patient data sharing. As consumerism has gripped the healthcare industry, health systems across the country are working to crack the code of...
Understanding litigation against drug, medical device manufactures
LifeSciencesIntelligence Legal challenges surrounding medical devices and pharmaceutical drugs have become increasingly prominent in the healthcare industry. In an episode of Healthcare Strategies, Janpaul Portal, Esq, Managing Director of pharmaceutical and...
A consumer-obsessed strategy is key to rebuilding primary care
PatientEngagementHIT While healthcare consumerism has reshaped the way patients engage and feel empowered in their care, for many health systems, it’s had the opposite effect, fragmenting patient care access and threatening the continuity of primary care...
FDA-approved insulin pumps used for insulin pump therapy
LifeSciencesIntelligence Insulin pump therapy, also known as continuous subcutaneous insulin infusion (CSII), has emerged as a significant advancement in diabetes technology over the last 50 years. Although commercial insulin pumps were introduced in the 1970s,...
How can payers be prepared to manage third-party security incidents?
HealthPayerIntelligence Security breaches and cyberattacks occur in the healthcare space at alarming rates, creating privacy concerns for all stakeholders involved. While provider organizations are the most common entities in healthcare that experience a security...
Comparing inflammatory bowel disease treatment options
PharmaNewsIntelligence Last month, AbbVie sponsored several presentations and posters at the European Crohn's and Colitis Organization’s (ECCO) annual congress. Among these abstracts was the SEQUENCE study, which compared risankizumab and ustekinumab...
Understanding HIV drug resistance, implications for treatment strategies
PharmaNewsIntelligence For HIV treatment, the emergence of drug resistance poses a significant challenge. Despite remarkable advancements in antiretroviral therapy (ART), the persistence of HIV in the body and its ability to mutate presents a constant threat to...
How can gene therapies address inherited blindness?
LifeSciencesIntelligence According to Boston Children’s Hospital, inherited retinal disorders are one primary cause of genetic blindness as they damage the retina and impair vision. While these conditions are rare, their impacts on vision can vary from mildly...
How a state agency built a public health database
PatientEngagementHIT Any good public health organization knows that when it’s designing a community intervention, it has to back it up with evidence. At Activate Allen County, a public health collaborative in Ohio, the group’s Health Atlas is laying...
Enhancing diabetes management with innovative insulin pump technology
LifeSciencesIntelligence In diabetes management, insulin pumps represent transformative technological breakthroughs that provide individuals with a vital pathway to improved health and enhanced quality of life. These portable medical devices have revolutionized...
Top patient engagement strategies for hospital discharge
PatientEngagementHIT Strong patient engagement during hospital discharge is a non-negotiable for most healthcare organizations. As hospitals continue to embrace value-based care models, which issue reimbursement based on a set of clinical quality measures, they...
Exploring Transparency-Rx’s pharmacy benefit manager partners
PharmaNewsIntelligence Transparency-Rx is a recently launched organization of transparent pharmacy benefit managers working towards addressing the ongoing challenges with pharmacy benefit managers (PBMs) that have hindered access to care and significantly...
Unraveling confusing AI regulations, their impact on life sciences
LifeSciencesIntelligence Only 9% of life sciences professionals believe they know and understand AI regulations well, revealed the Pistoia Alliance, a non-profit that engages major pharmaceutical companies in pre-competitive collaboration, in recently published...
In medicine’s push for workforce diversity, culture of belonging is key
PatientEngagementHIT In the past decade, and especially in the last five years, healthcare has been working to crack the code of embedding antiracism into the fabric of the industry through workforce diversity. But far from the quotas sometimes conjured when...
Using the PEMAT to assess patient education materials
PatientEngagementHIT As the push for greater patient health literacy gets stronger, the Patient Education Materials Assessment Tool (PEMAT) could be helpful to healthcare providers. Increasingly, healthcare industry experts are touting the role that patient...
3 ways to prepare for impending HIPAA Security Rule updates
HealthITSecurity In the decades since the HIPAA Security Rule was enacted, it has remained a crucial tool to covered entities and business associates as they navigate the multitude of cybersecurity risks that trouble the healthcare sector. HIPAA’s...
